A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection

NCT01043172 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

OTHER_GOV

Sponsor class

Conditions

Cholangiocarcinoma

Interventions

DRUG: Gemcitabine

Sponsor

National Cancer Center, Korea

Collaborators

[object Object]